OrbiMed Israel Partners II, L.P. plan to sell securities of Adicet Bio, Inc. under Form 144

OrbiMed Israel Partners II, L.P. filed Form 144 to notify SEC of plan to sell 40416 units of Adicet Bio, Inc. securities around 2026-04-08, with aggregate market value of $264,724.80. The total outstanding units is 9596407.0. The amount planned to be sold represents 0.42% of total outstanding units;